Morhaime Michael 4
Accession 0001352027-18-000014
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 7:05 PM ET
Size
42.8 KB
Accession
0001352027-18-000014
Insider Transaction Report
- Exercise/Conversion
Employee Stock Options
2018-02-20−66,667→ 66,666 totalExercise: $34.59Exp: 2025-11-13→ Common Stock, par value $0.000001 per share (66,667 underlying) - Exercise/Conversion
Employee Stock Options
2018-02-20−3,518→ 0 total(indirect: By Spouse)Exercise: $20.10Exp: 2024-11-14→ Common Stock, par value $0.000001 per share (3,518 underlying) - Exercise/Conversion
Employee Stock Options
2018-02-20−1,438→ 1,437 total(indirect: By Spouse)Exercise: $34.59Exp: 2025-11-13→ Common Stock, par value $0.000001 per share (1,438 underlying) - Exercise/Conversion
Employee Stock Options
2018-02-21−34,649→ 133,333 totalExercise: $41.09Exp: 2026-11-07→ Common Stock, par value $0.000001 per share (34,649 underlying) - Exercise/Conversion
Common Stock, par value $0.000001 per share
2018-02-20$34.59/sh+1,438$49,740→ 24,876 total(indirect: By Spouse) - Exercise/Conversion
Employee Stock Options
2018-02-20−66,666→ 0 totalExercise: $20.10Exp: 2024-11-14→ Common Stock, par value $0.000001 per share (66,666 underlying) - Exercise/Conversion
Employee Stock Options
2018-02-20−32,018→ 167,982 totalExercise: $41.09Exp: 2026-11-07→ Common Stock, par value $0.000001 per share (32,018 underlying) - Sale
Common Stock, par value $0.000001 per share
2018-02-20$71.03/sh−1,438$102,143→ 23,438 total(indirect: By Spouse) - Exercise/Conversion
Common Stock, par value $0.000001 per share
2018-02-20$34.59/sh+66,667$2,306,012→ 303,061 total - Exercise/Conversion
Common Stock, par value $0.000001 per share
2018-02-20$41.09/sh+32,018$1,315,620→ 268,412 total - Exercise/Conversion
Common Stock, par value $0.000001 per share
2018-02-20$20.10/sh+3,518$70,712→ 26,956 total(indirect: By Spouse) - Exercise/Conversion
Common Stock, par value $0.000001 per share
2018-02-20$41.09/sh+919$37,762→ 24,357 total(indirect: By Spouse) - Exercise/Conversion
Common Stock, par value $0.000001 per share
2018-02-20$20.10/sh+66,666$1,339,987→ 303,060 total - Sale
Common Stock, par value $0.000001 per share
2018-02-20$71.07/sh−32,018$2,275,414→ 236,394 total - Sale
Common Stock, par value $0.000001 per share
2018-02-20$71.03/sh−3,518$249,889→ 23,438 total(indirect: By Spouse) - Exercise/Conversion
Employee Stock Options
2018-02-20−919→ 1,837 total(indirect: By Spouse)Exercise: $41.09Exp: 2026-11-07→ Common Stock, par value $0.000001 per share (919 underlying) - Sale
Common Stock, par value $0.000001 per share
2018-02-20$71.07/sh−66,666$4,737,733→ 236,394 total - Sale
Common Stock, par value $0.000001 per share
2018-02-20$71.07/sh−66,667$4,737,804→ 236,394 total - Sale
Common Stock, par value $0.000001 per share
2018-02-21$70.82/sh−34,649$2,453,943→ 236,394 total - Sale
Common Stock, par value $0.000001 per share
2018-02-20$71.03/sh−919$65,278→ 23,438 total(indirect: By Spouse) - Exercise/Conversion
Common Stock, par value $0.000001 per share
2018-02-21$41.09/sh+34,649$1,423,727→ 271,043 total
- 401,354(indirect: See footnote)
Common Stock, par value $0.000001 per share
Footnotes (14)
- [F1]The price in Column 4 is a weighted average price. The prices actually received for the stock ranged from $71.00 to $71.22 per share. Mr. Morhaime has provided to the Company and, upon request, will provide any security holder of the Company or the SEC staff with information regarding the number of shares sold at each price within that range.
- [F10]The exercised options vested on November 6, 2017. One-half of the remaining unvested options will vest on each of November 6, 2018 and 2019.
- [F11]These options were fully vested on November 14, 2017.
- [F12]The exercised options vested on November 13, 2017. The remaining options will vest on November 13, 2018.
- [F13]The exercised options vested on November 7, 2017. One-half of the remaining options vest on each of November 7, 2018 and 2019.
- [F14]The exercised options vested on November 6, 2017. One-half of the remaining options will vest on each of November 6, 2018 and 2019.
- [F2]The price in Column 4 is a weighted average price. The prices actually received for the stock ranged from $71.01 to $71.07 per share. Mr. Morhaime has provided to the Company and, upon request, will provide any security holder of the Company or the SEC staff with information regarding the number of shares sold at each price within that range.
- [F3]Following the transactions reported on this form 4, Mr. Morhaime indirectly held, through his wife, (a) 12,861 shares of the Company's common stock and (b) 10,577 performance-vesting restricted stock units, each representing the right to receive one share of the Company's common stock.
- [F4]The price in Column 4 is a weighted average price. The prices actually received for the stock ranged from $70.75 to $71.1401 per share. Mr. Morhaime has provided to the Company and, upon request, will provide any security holder of the Company or the SEC staff with information regarding the number of shares sold at each price within that range.
- [F5]Following the transactions reported on this Form 4, Mr. Morhaime directly held (a) 166,395 performance-vesting restricted stock units, each representing the right to receive one share of the Company's common stock, and (b) 69,999 time-vesting restricted stock units, each representing the right to receive one share of the Company's common stock.
- [F6]Following the transactions reported on this Form 4, Mr. Morhaime indirectly held, through the Michael Morhaime Revocable Trust, 401,354 shares of the Company's common stock.
- [F7]These securities are held by the Michael Morhaime Revocable Trust.
- [F8]These options were fully vested on November 13, 2017.
- [F9]The exercised options vested on November 12, 2017. The remaining options will vest on November 12, 2018.
Documents
Issuer
Activision Blizzard, Inc.
CIK 0000718877
Related Parties
1- filerCIK 0001439532
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 7:05 PM ET
- Size
- 42.8 KB